Clinical Trial Update: BESPOKE Study of ctDNA Guided Immunotherapy

View source ↗

Summary

The BESPOKE trial evaluating ctDNA-guided immunotherapy has completed, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma

Snippet

Sponsor: Natera, Inc. | Conditions: Colorectal Cancer, Melanoma | Status: COMPLETED